newsfilter
← Latest News
GlobeNewswire·

Pharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025

ZUG, Switzerland, March 03, 2025 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living